264
Participants
Start Date
November 21, 2024
Primary Completion Date
July 31, 2027
Study Completion Date
December 31, 2027
dapagliflozin
Sodium-glucose cotransporter 2 inhibitor for 90 days during the acute kidney disease period.
Other anti-diabetic drug or no anti-diabetic drug
"Other anti-diabetic drug or no anti-diabetic drug for 90 days during the acute kidney disease period.~Other anti-diabetic drug includes metformin, sulfonylureas, meglitinides, dipeptidyl peptidase-4 inhibitor, insulin, α-glucosidase inhibitors, thiazolidinediones, and glucagon-like peptide-1 receptor agonist."
empagliflozin
Sodium-glucose cotransporter 2 inhibitor for 90 days during the acute kidney disease period.
canagliflozin
Sodium-glucose cotransporter 2 inhibitor for 90 days during the acute kidney disease period.
RECRUITING
National Taiwan University Hospital, Taipei
Chang Gung Memorial Hospital
OTHER
China Medical University Hospital
OTHER
National Taiwan University Hospital
OTHER